Monitoring the Course of Chronic Myelogenous Leukemia by Fluorescence in Situ Hybridization
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Seong D, Thall P, Kantarjian H, Talpaz M, Swantkowski J, Xu J
. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Res. 1998; 4(4):861-7.
View
2.
Kolb H, Schattenberg A, Goldman J, Hertenstein B, Jacobsen N, Arcese W
. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 1995; 86(5):2041-50.
View
3.
Joos S, Fink T, Ratsch A, Lichter P
. Mapping and chromosome analysis: the potential of fluorescence in situ hybridization. J Biotechnol. 1994; 35(2-3):135-53.
DOI: 10.1016/0168-1656(94)90032-9.
View
4.
Tkachuk D, Westbrook C, Andreeff M, Donlon T, Cleary M, Suryanarayan K
. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science. 1990; 250(4980):559-62.
DOI: 10.1126/science.2237408.
View
5.
Seong D, Giralt S, Fischer H, Hayes K, Glassman A, Arlinghaus R
. Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant. 1997; 19(6):565-70.
DOI: 10.1038/sj.bmt.1700700.
View